Clinical outcomes in 2003-33 and 2006-66 trials combined for patients with GEP-derived molecular subgroups. OS (A), EFS, (B), CR onset (C), and CRD (D). Subgroup designations are CD-1, CD-2, MMSET/FGFR3, MAF/MAFB, hyperdiploidy, low bone disease, myeloid, and proliferation.⁹  Similar colors were used for similar curves (blue represents favorable; yellow, CD-1; and red, unfavorable). P values for individual colors, or 1 color versus the rest.